Sha256: 5af2ff27ee29b70207a02450db9c8691d32983e1031eed527183c0500808fab3
Contents?: true
Size: 1.79 KB
Versions: 10
Compression:
Stored size: 1.79 KB
Contents
<?xml version="1.0" encoding="UTF-8"?>
<DetectedIssue xmlns="http://hl7.org/fhir">
<id value="ddi"/>
<meta>
<security>
<system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/>
<code value="HTEST"/>
<display value="test health data"/>
</security>
</meta>
<status value="final"/>
<code>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/>
<code value="DRG"/>
<display value="Drug Interaction Alert"/>
</coding>
</code>
<severity value="high"/>
<identifiedDateTime value="2014-01-05"/>
<author>
<reference value="Device/software"/>
</author>
<implicated>
<reference value="MedicationStatement/example001"/>
<display value="500 mg Acetaminophen tablet 1/day, PRN since 2010"/>
</implicated>
<implicated>
<reference value="MedicationRequest/medrx0331"/>
<display value="Warfarin 1 MG TAB prescribed Jan. 15, 2015"/>
</implicated>
<detail value="Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding."/>
<mitigation>
<action>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/>
<code value="13"/>
<display value="Stopped Concurrent Therapy"/>
</coding>
<text value="Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring"/>
</action>
<date value="2014-01-05"/>
<author>
<reference value="Practitioner/example"/>
<display value="Dr. Adam Careful"/>
</author>
</mitigation>
</DetectedIssue>
Version data entries
10 entries across 10 versions & 1 rubygems